To express the sense of the Senate on the Transformational Medical Technology Initiative of the Department of Defense.
What it does: Adds SEC. 762. SENSE OF SENATE ON THE TRANSFORMATIONAL MEDICAL TECHNOLOGY INITIATIVE OF THE DEPARTMENT OF DEFENSE at the end of subtitle D of title VIIWhat it changes
1 change to S. 2766 · shown in the bill's text
Adds SEC. 762. SENSE OF SENATE ON THE TRANSFORMATIONAL MEDICAL TECHNOLOGY INITIATIVE OF THE DEPARTMENT OF DEFENSE at the end of subtitle D of title VII
Adds a sectionIn S. 2766 · Public Print
(2) innovative technological approaches to achieve broad- spectrum medical countermeasures are a necessary component of the capacity of the Department to provide chemical-biological defense and force protection capabilities for the Armed Forces.
Inserted: SEC. 762. SENSE OF SENATE ON THE TRANSFORMATIONAL MEDICAL TECHNOLOGY INITIATIVE OF THE DEPARTMENT OF DEFENSE.
Inserted: (a) Findings.--The Senate finds the following:
Inserted: (1) The most recent Quadrennial Defense Review and other studies have identified the need to develop broad-spectrum medical countermeasures against the threat of genetically engineered bioterror agents.
Inserted: (2) The Transformational Medical Technology Initiative of the Department of Defense implements cutting edge transformational medical technologies and applies them to address the challenges of known, emerging, and bioengineered threats.
Inserted: (3) The Transformational Medical Technology Initiative is designed to provide such technologies in a much shorter timeframe, and at lower cost, than is required with traditional approaches.
Inserted: (b) Sense of Senate.--It is the sense of the Senate that--
Inserted: (1) the Transformational Medical Technology Initiative is an important effort to provide needed capability within the Department of Defense to field effective broad-spectrum countermeasures against a significant array of current and future biological threats; and
Inserted: (2) innovative technological approaches to achieve broad-spectrum medical countermeasures are a necessary component of the capacity of the Department to provide chemical-biological defense and force protection capabilities for the Armed Forces.
Original wording
At the end of subtitle D of title VII, add the following:
Read automatically from the Congressional Record. Check the original before relying on it.
As printed
SA 4537. Mr. WARNER (for Mr. Cornyn) proposed an amendment to the bill S. 2766, to authorize appropriations for fiscal year 2007 for military activities of the Department of Defense, for military construction, and for defense activities of the Department of Energy, to prescribe personnel strengths for such fiscal year for the Armed Forces, and for other purposes; as follows:
At the end of subtitle D of title VII, add the following:
SEC. 762. SENSE OF SENATE ON THE TRANSFORMATIONAL MEDICAL TECHNOLOGY INITIATIVE OF THE DEPARTMENT OF DEFENSE.
(a) Findings.--The Senate finds the following:
(1) The most recent Quadrennial Defense Review and other studies have identified the need to develop broad-spectrum medical countermeasures against the threat of genetically engineered bioterror agents.
(2) The Transformational Medical Technology Initiative of the Department of Defense implements cutting edge transformational medical technologies and applies them to address the challenges of known, emerging, and bioengineered threats.
(3) The Transformational Medical Technology Initiative is designed to provide such technologies in a much shorter timeframe, and at lower cost, than is required with traditional approaches.
(b) Sense of Senate.--It is the sense of the Senate that--
(1) the Transformational Medical Technology Initiative is an important effort to provide needed capability within the Department of Defense to field effective broad-spectrum countermeasures against a significant array of current and future biological threats; and
(2) innovative technological approaches to achieve broad-spectrum medical countermeasures are a necessary component of the capacity of the Department to provide chemical-biological defense and force protection capabilities for the Armed Forces.
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Senate amendment submitted
June 22, 2006
View full timeline
Senate amendment submitted
June 22, 2006
Senate amendment agreed to: Amendment SA 4537 agreed to in Senate by Unanimous Consent.
June 22, 2006
Senate amendment proposed (on the floor): Amendment SA 4537 proposed by Senator Warner for Senator Cornyn.
June 22, 2006
Amendment SA 4537 proposed by Senator Warner for Senator Cornyn. (consideration: CR S6377-6392; text: CR S6387-6388) To express the sense of the Senate on the Transformational Medical Technology Initiative of the Department of Defense.
June 22, 2006
Amendment SA 4537 agreed to in Senate by Unanimous Consent.
June 22, 2006